[Clinical experiences with the Kö 1366 (Bunitrololhydrochloride) beta receptor blockader and the combination Kö 1366/Isosorbitdinitrate in patients with coronary disease].
D003327:Coronary Disease / Q000188:drug therapy*; D004338:Drug Combinations; D004341:Drug Evaluation; D005080:Exercise Test; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007548:Isosorbide Dinitrate / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects; D011412:Propanolamines / Q000494:pharmacology / Q000627:therapeutic use*
D004338:Drug Combinations; D011412:Propanolamines; D007548:Isosorbide Dinitrate
Klinische Erfahrungen mit dem Beta-Rezeptorenblocker Kö 1366 (Bunitrololhydrochlorid) und der Kombination Kö 1366/Isosorbitdinitrat bei Koronarkranken